Summary Recently disclosed court documents show that Sinovac Biotech’s (NASDAQ: SVA) CEO bribed a member of the Chinese Food and Drug Administration to assist its vaccine clinical trial and approval Bribery is a clear violation of Foreign Corrupt Practices Act […]